Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 7

Results For "Indian-Council-of-Medical-Research"

74 News Found

ICMR approves Meril’s Rapid Antigen Test kit
Drug Approval | November 25, 2021

ICMR approves Meril’s Rapid Antigen Test kit

The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes


Covaxin well tolerated with no safety concerns: Lancet
News | November 12, 2021

Covaxin well tolerated with no safety concerns: Lancet

Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%


Takeda receives the Arogaya CIBioD Leadership Award
Public Health | November 10, 2021

Takeda receives the Arogaya CIBioD Leadership Award

It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients


AstraZeneca partners with India-Sweden Healthcare Innovation Centre and AIIMS to upskill nurses
Public Health | October 28, 2021

AstraZeneca partners with India-Sweden Healthcare Innovation Centre and AIIMS to upskill nurses

This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one


ISA celebrates October as stroke awareness month
Healthcare | October 21, 2021

ISA celebrates October as stroke awareness month

India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50


Covaxin for kids gets nod, final approval awaited
Drug Approval | October 12, 2021

Covaxin for kids gets nod, final approval awaited

The two doses of Covaxin are likely to be administered to children with a gap of 28 days


ICMR to use drones for vaccine delivery
Supply Chain | September 14, 2021

ICMR to use drones for vaccine delivery

ICMR receives conditional exemption from Drone Rules 2021 to speed up vaccine delivery in the A&N Islands, Manipur and Nagaland


Govt revises NLEM and slashes prices of 39 drugs
Policy | September 04, 2021

Govt revises NLEM and slashes prices of 39 drugs

At present 18 per cent of the local pharmaceutical market is under government's price control


India’s gets its first bio-bank for heart failure research
Drug Approval | August 06, 2021

India’s gets its first bio-bank for heart failure research

Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology


AYUSH 64 effective in mild and moderate COVID 19
Drug Approval | August 03, 2021

AYUSH 64 effective in mild and moderate COVID 19

It works as an adjunct to standard care based on robust clinical trials